£2.2M
The investment was backed by the South West Investment Fund via The FSE Group.
GP
Green Park Pharma
Green Park Pharma formulates liquid alternatives to standard tablet medications.
South West England, UK
£4.4MTotal raised
Green Park Pharma develops patented, stable liquid formulations of existing medications to help patients who struggle with swallowing traditional tablets.
Categories
Team
RR
Richard Reavley
Group CEO
Investors
- £2.2M
- £2.2M
Funding history
£2.2M
The pre-series A round was backed by The FSE Group through the South West Investment Fund.